Skip to main content
SpringerLink
Log in

Exploring regulatory network of metabolism through liver research

  • Review Article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

In recent years, the techniques in molecular biology have been dramatically advanced, and consequently the landscape of metabolism research has undergone a remarkable change. One of the emerging pictures as the fruits of these advancements is one depicting the regulation of systemic metabolism through inter-organ networks involving multiple tissues, either via humoral factors, which are secreted from one tissue and conveyed to their remote target tissues, or through neuronal networks which are integrated by the central nervous system. In addition, the progress in high-throughput research tools enabled detailed characterization and deeper understanding of the nature of human genome, which has attracted much attention to the importance of various non-coding RNAs species. These non-coding RNAs are often co-expressed and co-regulated with adjacent protein coding genes, adding higher levels of complexities by them functioning together as a system and often influencing biologically important pathways in a cooperative manner. Here in this review several examples of these regulatory network systems are presented, illustrating the significance of them in systemic metabolism, with a possible future research direction also being proposed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–56. https://doi.org/10.1210/jc.2004-0395.

    Article  CAS  PubMed  Google Scholar 

  2. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85–97.

    Article  CAS  Google Scholar 

  3. Xu H, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30. https://doi.org/10.1172/jci200319451.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Weisberg SP, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808. https://doi.org/10.1172/jci200319246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Priest C, Tontonoz P. Inter-organ cross-talk in metabolic syndrome. Nat Metab. 2019;1:1177–88. https://doi.org/10.1038/s42255-019-0145-5.

    Article  PubMed  Google Scholar 

  6. Kadowaki T, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784–92. https://doi.org/10.1172/jci29126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yamauchi T, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288–95.

    Article  CAS  Google Scholar 

  8. Kubota N, et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 2007;6:55–68.

    Article  CAS  Google Scholar 

  9. Yamauchi T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007;13:332–9.

    Article  CAS  Google Scholar 

  10. Holland WL, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med. 2011;17:55–63.

    Article  CAS  Google Scholar 

  11. Awazawa M, et al. Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochem Biophys Res Commun. 2009;382:51–6.

    Article  CAS  Google Scholar 

  12. Shklyaev S, et al. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. PNAS. 2003;100:14217–22. https://doi.org/10.1073/pnas.2333912100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Xu A, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112:91–100.

    Article  CAS  Google Scholar 

  14. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7:85–96.

    Article  CAS  Google Scholar 

  15. Shimomura I, et al. Decreased IRS-2 and Increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob Mice. Mol Cell. 2000;6:77–86.

    Article  CAS  Google Scholar 

  16. Awazawa M, et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab. 2011;13:401–12.

    Article  CAS  Google Scholar 

  17. Xing Z, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Investig. 1998;101:311–20.

    Article  CAS  Google Scholar 

  18. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-Reactive protein, Interleukin 6, and risk of developing Type 2 diabetes mellitus. JAMA. 2001;286:327–34. https://doi.org/10.1001/jama.286.3.327.

    Article  CAS  PubMed  Google Scholar 

  19. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived Interleukin-6. Physiol Rev. 2008;88:1379–406. https://doi.org/10.1152/physrev.90100.2007.

    Article  CAS  Google Scholar 

  20. Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. Interleukin-6 Is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes. 2004;53:1643–8. https://doi.org/10.2337/diabetes.53.7.1643.

    Article  CAS  PubMed  Google Scholar 

  21. Consortium EP, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74. https://doi.org/10.1038/nature11247.

    Article  CAS  Google Scholar 

  22. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861–74. https://doi.org/10.1038/nrg3074.

    Article  CAS  PubMed  Google Scholar 

  23. Davis BN, Hata A. Regulation of MicroRNA biogenesis: a miRiad of mechanisms. Cell Commun Signal. 2009;7:18. https://doi.org/10.1186/1478-811X-7-18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gromak N. Intronic microRNAs: a crossroad in gene regulation. Biochem Soc Trans. 2012;40:759–61. https://doi.org/10.1042/BST20120023.

    Article  CAS  PubMed  Google Scholar 

  25. Mikkola ML, et al. Ectodysplasin, a protein required for epithelial morphogenesis, is a novel TNF homologue and promotes cell-matrix adhesion. Mech Dev. 1999;88:133–46.

    Article  CAS  Google Scholar 

  26. Mikkola ML. Molecular aspects of hypohidrotic ectodermal dysplasia. Am J Med Genet A. 2009;149A:2031–6. https://doi.org/10.1002/ajmg.a.32855.

    Article  CAS  PubMed  Google Scholar 

  27. Lindfors PH, Voutilainen M, Mikkola ML. Ectodysplasin/NF-kappaB signaling in embryonic mammary gland development. J Mammary Gland Biol Neoplasia. 2013;18:165–9. https://doi.org/10.1007/s10911-013-9277-5.

    Article  PubMed  Google Scholar 

  28. Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia. 2012;55:2565–82. https://doi.org/10.1007/s00125-012-2644-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ozsolak F, et al. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell. 2010;143:1018–29. https://doi.org/10.1016/j.cell.2010.11.020.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Diabetic Medicine, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo, 162-8655, Japan

    Motoharu Awazawa

Authors
  1. Motoharu Awazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Motoharu Awazawa.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Human and animal rights statement

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Awazawa, M. Exploring regulatory network of metabolism through liver research. Diabetol Int 12, 343–348 (2021). https://doi.org/10.1007/s13340-021-00536-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-021-00536-z

Keywords

Search

Navigation